Therefore, to objectively evaluate the diagnostic effects of LPIN1 and TNFAIP3, it is necessary to strictly control the inclusion and exclusion criteria of PD subjects and collect more complete, accurate clinical data to regulate the influence of other miscellaneous variables on experiment. The gene discussed is LPIN1; the disease is Parkinson disease.